Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.910
+0.340 (9.52%)
At close: Nov 13, 2026, 4:00 PM EST
3.920
+0.010 (0.26%)
After-hours: Nov 13, 2026, 7:59 PM EST
Aquestive Therapeutics Employees
Aquestive Therapeutics had 147 employees as of December 31, 2025. The number of employees increased by 5 or 3.52% compared to the previous year. That makes Aquestive Therapeutics the 29,013th largest employer in the world and 3,667th in the United States.
Employees
147
Change (1Y)
5
Growth (1Y)
3.52%
Revenue / Employee
$332,224
Profits / Employee
-$539,299
Market Cap
491.44M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 147 | 5 | 3.52% |
| Dec 31, 2024 | 142 | 7 | 5.19% |
| Dec 31, 2023 | 135 | 5 | 3.85% |
| Dec 31, 2022 | 130 | -27 | -17.20% |
| Dec 31, 2021 | 157 | -30 | -16.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evotec SE | 4,379 |
| Tilray Brands | 3,595 |
| Aurora Cannabis | 1,028 |
| Emergent BioSolutions | 900 |
| Kamada | 462 |
| Collegium Pharmaceutical | 423 |
| Lifecore Biomedical | 382 |
| Evolus | 365 |
AQST News
- 6 days ago - Aquestive Therapeutics to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 10 days ago - Aquestive Therapeutics to Present Data at the 2026 ACAAI Annual Meeting - GlobeNewsWire
- 11 days ago - Aquestive Therapeutics Earnings Call Transcript: Q3 2026 - Transcripts
- 11 days ago - Aquestive Therapeutics Earnings release: Q3 2026 - Filings
- 11 days ago - Aquestive Therapeutics Quarterly report: Q3 2026 - Filings
- 11 days ago - Aquestive Therapeutics Slides: Q3 2026 - Filings
- 11 days ago - Aquestive Therapeutics reports Q3 EPS (13c), consensus (14c) - TheFly
- 11 days ago - Aquestive Therapeutics backs FY26 revenue view $46M-$50M, consensus $51.04M - TheFly